GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eisai Co Ltd (FRA:EII) » Definitions » Cyclically Adjusted PS Ratio

Eisai Co (FRA:EII) Cyclically Adjusted PS Ratio : 0.89 (As of May. 18, 2024)


View and export this data going back to . Start your Free Trial

What is Eisai Co Cyclically Adjusted PS Ratio?

As of today (2024-05-18), Eisai Co's current share price is €40.85. Eisai Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €45.99. Eisai Co's Cyclically Adjusted PS Ratio for today is 0.89.

The historical rank and industry rank for Eisai Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

FRA:EII' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.64   Med: 0.91   Max: 1.54
Current: 0.92

During the past years, Eisai Co's highest Cyclically Adjusted PS Ratio was 1.54. The lowest was 0.64. And the median was 0.91.

FRA:EII's Cyclically Adjusted PS Ratio is ranked better than
73.56% of 745 companies
in the Drug Manufacturers industry
Industry Median: 2.17 vs FRA:EII: 0.92

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Eisai Co's adjusted revenue per share data for the three months ended in Mar. 2024 was €4.079. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €45.99 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Eisai Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Eisai Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eisai Co Cyclically Adjusted PS Ratio Chart

Eisai Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.98 0.95 0.75 0.98 0.84

Eisai Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.98 1.29 1.09 0.94 0.84

Competitive Comparison of Eisai Co's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Eisai Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eisai Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eisai Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Eisai Co's Cyclically Adjusted PS Ratio falls into.



Eisai Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Eisai Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=40.85/45.99
=0.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eisai Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Eisai Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=4.079/107.2000*107.2000
=4.079

Current CPI (Mar. 2024) = 107.2000.

Eisai Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 13.413 98.000 14.672
201409 13.740 98.500 14.954
201412 13.232 97.900 14.489
201503 15.002 97.900 16.427
201506 14.005 98.400 15.257
201509 14.114 98.500 15.361
201512 15.908 98.100 17.384
201603 13.480 97.900 14.761
201606 16.173 98.100 17.673
201609 16.253 98.000 17.779
201612 15.901 98.400 17.323
201703 15.017 98.100 16.410
201706 15.896 98.500 17.300
201709 15.146 98.800 16.434
201712 16.167 99.400 17.436
201803 17.129 99.200 18.510
201806 16.639 99.200 17.981
201809 16.732 99.900 17.955
201812 17.175 99.700 18.467
201903 19.487 99.700 20.953
201906 17.596 99.800 18.901
201909 17.117 100.100 18.331
201912 21.502 100.500 22.935
202003 24.550 100.300 26.239
202006 19.067 99.900 20.460
202009 16.990 99.900 18.232
202012 20.029 99.300 21.622
202103 15.913 99.900 17.076
202106 5.230 99.500 5.635
202109 17.595 100.100 18.843
202112 5.505 100.100 5.895
202203 5.099 101.100 5.407
202206 4.537 101.800 4.778
202209 4.285 103.100 4.455
202212 4.576 104.100 4.712
202303 4.829 104.400 4.959
202306 4.485 105.200 4.570
202309 3.903 106.200 3.940
202312 3.946 106.800 3.961
202403 4.079 107.200 4.079

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Eisai Co  (FRA:EII) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Eisai Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Eisai Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Eisai Co (FRA:EII) Business Description

Industry
Traded in Other Exchanges
Address
4-6-10 Koishikawa, Bunkyo-ku, Tokyo, JPN, 112-8088
Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of a pharmaceutical business and other businesses. The pharmaceutical business is categorized by region, including Japan, Americas, China, Asia, and Europe, Middle East, and Africa. Eisai also reports a consumer healthcare business for Japan. The vast majority of the company's revenue is derived by its Japanese pharmaceutical business, followed by its Americas pharmaceuticals segment. The company utilizes licensing strategies in order to expand its research, development, manufacturing, and marketing capabilities.

Eisai Co (FRA:EII) Headlines

No Headlines